Stock Track | MoonLake Immunotherapeutics Soars 5.58% Following Wolfe Research Upgrade to Outperform

Stock Track

May 19, 2025

MoonLake Immunotherapeutics (MLTX) saw its stock price surge 5.58% in pre-market trading on Monday, following a significant upgrade from Wolfe Research. The firm raised its rating on MoonLake from Peer Perform to Outperform, signaling increased confidence in the company's future prospects.

Wolfe Research not only upgraded MoonLake but also set a price target of $61 for the stock. This bullish stance aligns with the overall positive sentiment among analysts covering MoonLake Immunotherapeutics. According to FactSet, the company currently has an average rating of "buy" from analysts, with a mean price target of $80.43.

The upgrade and the resulting stock price jump highlight the market's optimism about MoonLake's potential in the competitive immunotherapeutics sector. Investors appear to be responding positively to the improved outlook, driving the stock's pre-market rally. As trading continues, market participants will be closely watching to see if MoonLake can maintain this momentum and move closer to the analysts' price targets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1166137758"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166137758\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166137758?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-19 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166137758","market":"sg","top_or_hot":-1,"title":"Stock Track | MoonLake Immunotherapeutics Soars 5.58% Following Wolfe Research Upgrade to Outperform","media":"Stock Track","content":"<p>MoonLake Immunotherapeutics (MLTX) saw its stock price surge 5.58% in pre-market trading on Monday, following a significant upgrade from Wolfe Research. The firm raised its rating on MoonLake from Peer Perform to Outperform, signaling increased confidence in the company's future prospects.</p>\n\n<p>Wolfe Research not only upgraded MoonLake but also set a price target of $61 for the stock. This bullish stance aligns with the overall positive sentiment among analysts covering MoonLake Immunotherapeutics. According to FactSet, the company currently has an average rating of \"buy\" from analysts, with a mean price target of $80.43.</p>\n\n<p>The upgrade and the resulting stock price jump highlight the market's optimism about MoonLake's potential in the competitive immunotherapeutics sector. Investors appear to be responding positively to the improved outlook, driving the stock's pre-market rally. As trading continues, market participants will be closely watching to see if MoonLake can maintain this momentum and move closer to the analysts' price targets.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MoonLake Immunotherapeutics Soars 5.58% Following Wolfe Research Upgrade to Outperform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MoonLake Immunotherapeutics Soars 5.58% Following Wolfe Research Upgrade to Outperform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-19 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MoonLake Immunotherapeutics (MLTX) saw its stock price surge 5.58% in pre-market trading on Monday, following a significant upgrade from Wolfe Research. The firm raised its rating on MoonLake from Peer Perform to Outperform, signaling increased confidence in the company's future prospects.</p>\n\n<p>Wolfe Research not only upgraded MoonLake but also set a price target of $61 for the stock. This bullish stance aligns with the overall positive sentiment among analysts covering MoonLake Immunotherapeutics. According to FactSet, the company currently has an average rating of \"buy\" from analysts, with a mean price target of $80.43.</p>\n\n<p>The upgrade and the resulting stock price jump highlight the market's optimism about MoonLake's potential in the competitive immunotherapeutics sector. Investors appear to be responding positively to the improved outlook, driving the stock's pre-market rally. As trading continues, market participants will be closely watching to see if MoonLake can maintain this momentum and move closer to the analysts' price targets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MLTX","symbol_name":"MoonLake Immunotherapeutics","start_time":0,"source_url":"","article_id":"1166137758","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166137758","pubTimestamp":1747662046,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MoonLake Immunotherapeutics  saw its stock price surge 5.58% in pre-market trading on Monday, following a significant upgrade from Wolfe Research. The firm raised its rating on MoonLake from Peer Perform to Outperform, signaling increased confidence in the company's future prospects.The upgrade and the resulting stock price jump highlight the market's optimism about MoonLake's potential in the competitive immunotherapeutics sector. Investors appear to be responding positively to the improved out","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MLTX":"MoonLake Immunotherapeutics"},"translate_title":"Wolfe Research上调至跑赢大盘后，MoonLake Immunotherapeutics股价飙升5.58%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MLTX":1},"content_text":"MoonLake Immunotherapeutics (MLTX) saw its stock price surge 5.58% in pre-market trading on Monday, following a significant upgrade from Wolfe Research. The firm raised its rating on MoonLake from Peer Perform to Outperform, signaling increased confidence in the company's future prospects.\nWolfe Research not only upgraded MoonLake but also set a price target of $61 for the stock. This bullish stance aligns with the overall positive sentiment among analysts covering MoonLake Immunotherapeutics. According to FactSet, the company currently has an average rating of \"buy\" from analysts, with a mean price target of $80.43.\nThe upgrade and the resulting stock price jump highlight the market's optimism about MoonLake's potential in the competitive immunotherapeutics sector. Investors appear to be responding positively to the improved outlook, driving the stock's pre-market rally. As trading continues, market participants will be closely watching to see if MoonLake can maintain this momentum and move closer to the analysts' price targets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}